ENANTA PHARMACEUTICALS, INC Operating Leases, Rent Expense
ENANTA PHARMACEUTICALS, INC (ENTA) reported Operating Leases, Rent Expense of $2.49 million for the 12-month period ending 2019-09-30, per its 10-K filed 2019-11-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-11-27
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2019-09-30 was $623.00K, a 21.21% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2019-06-30 was $623.00K, a 23.12% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2019-03-31 was $623.00K, a 22.88% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for the quarter ending 2018-12-31 was $623.00K, a 23.12% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2019 was $2.49M, a 22.58% increase from fiscal 2018.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2018 was $2.03M, a 0.40% increase from fiscal 2017.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2017 was $2.02M, a 0.00% change from fiscal 2016.
- ENANTA PHARMACEUTICALS, INC operating leases, rent expense for fiscal 2016 was $2.02M, a 52.71% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $623.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.25M derived: sum of 2 quarters · filed 2019-11-27 | $1.87M derived: sum of 3 quarters · filed 2019-11-27 | $2.49M 10-K · filed 2019-11-27 |
| 2019-06-30 | $623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $1.25M derived: sum of 2 quarters · filed 2019-08-09 | $1.87M 10-Q · filed 2019-08-09 | $2.38M derived: sum of 4 quarters · filed 2019-11-27 |
| 2019-03-31 | $623.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $1.25M 10-Q · filed 2019-05-10 | $1.76M derived: sum of 3 quarters · filed 2019-11-27 | $2.27M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-12-31 | $623.00K 10-Q · filed 2019-02-08 | $1.14M derived: sum of 2 quarters · filed 2019-11-27 | $1.64M derived: sum of 3 quarters · filed 2019-11-27 | $2.15M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-09-30 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.02M derived: sum of 2 quarters · filed 2019-11-27 | $1.53M derived: sum of 3 quarters · filed 2019-11-27 | $2.03M 10-K · filed 2019-11-27 |
| 2018-06-30 | $506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $1.01M derived: sum of 2 quarters · filed 2019-08-09 | $1.52M 10-Q · filed 2019-08-09 | $2.02M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $1.01M 10-Q · filed 2019-05-10 | $1.52M derived: sum of 3 quarters · filed 2019-11-27 | $2.02M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $506.00K 10-Q · filed 2019-02-08 | $1.01M derived: sum of 2 quarters · filed 2019-11-27 | $1.52M derived: sum of 3 quarters · filed 2019-11-27 | $2.02M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.01M derived: sum of 2 quarters · filed 2019-11-27 | $1.52M derived: sum of 3 quarters · filed 2019-11-27 | $2.02M 10-K · filed 2019-11-27 |
| 2017-06-30 | $506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | $1.01M derived: sum of 2 quarters · filed 2018-08-09 | $1.52M 10-Q · filed 2018-08-09 | $2.02M derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-03-31 | $507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | $1.01M 10-Q · filed 2018-05-10 | $1.52M derived: sum of 3 quarters · filed 2018-11-29 | $2.02M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-12-31 | $506.00K 10-Q · filed 2018-02-09 | $1.01M derived: sum of 2 quarters · filed 2018-11-29 | $1.52M derived: sum of 3 quarters · filed 2018-11-29 | $2.02M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-09-30 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $1.01M derived: sum of 2 quarters · filed 2018-11-29 | $1.52M derived: sum of 3 quarters · filed 2018-11-29 | $2.02M 10-K · filed 2018-11-29 |
| 2016-06-30 | $506.00K 10-Q · filed 2016-08-09 | $1.01M derived: sum of 2 quarters · filed 2016-08-09 | $1.52M 10-Q · filed 2017-08-09 | $2.02M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $507.00K 10-Q · filed 2016-05-10 | $1.01M 10-Q · filed 2017-05-10 | $1.52M derived: sum of 3 quarters · filed 2017-12-11 | $1.86M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $506.00K 10-Q · filed 2017-02-09 | $1.01M derived: sum of 2 quarters · filed 2017-12-11 | $1.35M derived: sum of 3 quarters · filed 2017-12-11 | $1.59M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $846.00K derived: sum of 2 quarters · filed 2017-12-11 | $1.09M derived: sum of 3 quarters · filed 2017-12-11 | $1.33M 10-K · filed 2017-12-11 |
| 2015-06-30 | $341.00K 10-Q · filed 2016-08-09 | $584.00K derived: sum of 2 quarters · filed 2016-08-09 | $821.00K 10-Q · filed 2016-08-09 | $1.06M derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $243.00K 10-Q · filed 2016-05-10 | $480.00K 10-Q · filed 2016-05-10 | $717.00K derived: sum of 3 quarters · filed 2016-12-09 | $954.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $237.00K 10-Q · filed 2016-02-09 | $474.00K derived: sum of 2 quarters · filed 2016-12-09 | $711.00K derived: sum of 3 quarters · filed 2016-12-09 | $948.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $474.00K derived: sum of 2 quarters · filed 2016-12-09 | $711.00K derived: sum of 3 quarters · filed 2016-12-09 | $948.00K 10-K · filed 2016-12-09 |
| 2014-06-30 | $237.00K 10-Q · filed 2015-08-10 | $474.00K derived: sum of 2 quarters · filed 2015-08-10 | $711.00K 10-Q · filed 2015-08-10 | $948.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $237.00K 10-Q · filed 2015-05-08 | $474.00K 10-Q · filed 2015-05-08 | $711.00K derived: sum of 3 quarters · filed 2015-12-11 | $948.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $237.00K 10-Q · filed 2015-02-06 | $474.00K derived: sum of 2 quarters · filed 2015-12-11 | $711.00K derived: sum of 3 quarters · filed 2015-12-11 | $948.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $474.00K derived: sum of 2 quarters · filed 2015-12-11 | $711.00K derived: sum of 3 quarters · filed 2015-12-11 | $948.00K 10-K · filed 2015-12-11 |
| 2013-06-30 | $237.00K 10-Q · filed 2014-08-12 | $474.00K derived: sum of 2 quarters · filed 2014-08-12 | $711.00K 10-Q · filed 2014-08-12 | $948.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $237.00K 10-Q · filed 2014-05-12 | $474.00K 10-Q · filed 2014-05-12 | $711.00K derived: sum of 3 quarters · filed 2014-12-11 | $948.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | $237.00K 10-Q · filed 2014-02-13 | $474.00K derived: sum of 2 quarters · filed 2014-12-11 | $711.00K derived: sum of 3 quarters · filed 2014-12-11 | $948.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-09-30 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $474.00K derived: sum of 2 quarters · filed 2014-12-11 | $711.00K derived: sum of 3 quarters · filed 2014-12-11 | $948.00K 10-K · filed 2014-12-11 |
| 2012-06-30 | $237.00K 10-Q · filed 2013-08-12 | $474.00K derived: sum of 2 quarters · filed 2013-08-12 | $711.00K 10-Q · filed 2013-08-12 | |
| 2012-03-31 | $237.00K 10-Q · filed 2013-05-15 | $474.00K 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | $2.00M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |